ADMS - Adamas Pharmaceuticals Inc
Close
8.22
0.060 0.730%
Share volume: 0
Last Updated: Tue 23 Nov 2021 10:00:01 PM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$8.16
0.06
0.74%
Summary score
32%
Profitability
37%
Dept financing
23%
Liquidity
48%
Performance
25%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2017 - 30-Jun-2021
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
154.76%
Return on assets
-10.55%
Return on sales
-545.74%
Return on invested capital
78.21%
Total debt ratio
84.15%
Debt ratio change over timeo
-0.58%
Current Ratio
7.05%
Quick Ratio
6.85%
Cash Position Ratio
5.93%
Short-term ratios 30-Jun-2020 - 30-Jun-2021
The data are presented for the financials results of the quarters of the last year.
Return on equity
41.32%
Return on assets
-7.7%
Return on sales
-51.43%
Return on invested capital
24.34%
Total debt ratio
116.72%
Debt ratio change over timeo
-0.35%
Current Ratio
4.46%
Quick Ratio
4.2%
Cash Position Ratio
3.45%
Last quarter ratios 30-Jun-2021
The data are presented for the financials results of the last quarter.
Return on equity
306.07%
Return on assets
-6.08%
Return on sales
-41.67%
Return on invested capital
-93.77%
Total debt ratio
102.68%
Debt ratio change over time
-2.09%
Current Ratio
5.3%
Quick Ratio
4.94%
Cash Position Ratio
4.19%
Performance ratios (change over 4 years) 30-Jun-2017 - 30-Jun-2021
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-1.37%
Return on assets
-101.6%
Return on sales
626.45%
Return on invested capital
-98.29%
Total debt ratio
-57.51%
Debt ratio change over time
-0.58%
Current Ratio
-0.14%
Quick Ratio
-0.23%
Cash Position Ratio
-0.33%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ADMS | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 154.76% | 0% | 0% | 22.62% |
| Return on assets | -10.55% | 0% | 0% | -9.75% |
| Return on sales | -545.74% | 0% | 0% | -2017.42% |
| Return on invested capital | 78.21% | 0% | 0% | 66.76% |
| Profitability | 50% | 0% | 50% | 25% |
| Total debt ratio | 84.15% | 0% | 0% | 108.98% |
| Debt ratio change over time | -0.58% | 0% | 0% | -0.65% |
| Dept financing | 19% | 0% | 25% | 25% |
| Current Ratio | 4.46% | 0% | 0% | 8.37% |
| Quick Ratio | 4.2% | 0% | 0% | 8.37% |
| Cash Position Ratio | 3.45% | 0% | 0% | 8.07% |
| Liquididy | 75% | 0% | 0% | 64% |
| Short-term ratios | ADMS | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 41.32% | 0% | 0% | -23.1% |
| Return on assets | -7.7% | 0% | 0% | -7.41% |
| Return on sales | -51.43% | 0% | 0% | -3524.38% |
| Return on invested capital | 24.34% | 0% | 0% | 87.65% |
| Profitability | 32% | 0% | 50% | 25% |
| Total debt ratio | 116.72% | 0% | 0% | 58.83% |
| Debt ratio change over time | -0.35% | 0% | 0% | 0.08% |
| Dept financing | 25% | 0% | 0% | 38% |
| Current Ratio | 4.46% | 0% | 0% | 8.37% |
| Quick Ratio | 4.2% | 0% | 0% | 8.37% |
| Cash Position Ratio | 3.45% | 0% | 0% | 8.07% |
| Liquididy | 37% | 0% | 0% | 75% |